Literature DB >> 3280119

Evolution of cancer genes as a mutation-driven process.

H M Temin1.   

Abstract

Cancer is primarily a somatic genetic disease resulting from the accumulation of several precancerous mutations in a cell lineage. The evolution of highly oncogenic retroviruses has been used as a model for the evolution of a cancer cell. The properties of intermediates between one set of replication-competent retrovirus and protooncogene progenitors and the homologous highly oncogenic retrovirus were analyzed to differentiate between selection-driven and mutation-driven models of this evolution. In this case and in some other cases where sufficient data are available, it appears that the intermediates in the evolution of highly oncogenic retroviruses are not transforming, indicating that they were not formed in a purely selection-driven process. Furthermore, analysis of retrovirus mutation rates indicates that there is a high rate of mutation in retrovirus replication such that the evolution of highly oncogenic retroviruses could be mutation-driven. Other evidence is mentioned suggesting that oncogenesis in general is at least partially mutation-driven, although mutational mechanisms are involved that are different from those involved in the evolution of highly oncogenic retroviruses.

Entities:  

Mesh:

Year:  1988        PMID: 3280119

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Retroviral recombination during reverse transcription.

Authors:  D W Goodrich; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Oncogene expression in primary myelodysplasia: correlation with haematological, karyotypic, and clinical progression.

Authors:  R M Hutchinson; J H Pringle; S C Knight; I Lauder; A Potter; C Jagger
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

3.  A retroviral promoter is sufficient to convert proto-src to a transforming gene that is distinct from the src gene of Rous sarcoma virus.

Authors:  H Zhou; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Recombinant BALB and Harvey sarcoma viruses with normal proto-ras-coding regions transform embryo cells in culture and cause tumors in mice.

Authors:  K Cichutek; P H Duesberg
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Evidence that retroviral transduction is mediated by DNA not by RNA.

Authors:  D W Goodrich; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Lethal mutagenesis of HIV with mutagenic nucleoside analogs.

Authors:  L A Loeb; J M Essigmann; F Kazazi; J Zhang; K D Rose; J I Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 7.  Cytokine therapeutics: lessons from interferon alpha.

Authors:  J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

Review 8.  Reflections on viruses and cancer.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

9.  Unmutated proto-src coding region is tumorigenic if expressed from the promoter of Rous sarcoma virus: implications for the gene-mutation hypothesis of cancer.

Authors:  Y Wu; H Zhou; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 10.  Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation.

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.